Don Stablein

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 681 citations · Full text

Opioid Epidemic, Comparative Effectiveness, Substance Abuse +10

Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease

Stanley C. Jordan, Dolly B. Tyan, Don Stablein et al. · Journal of the American Society of Nephrology · 2004 · 430 citations

Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure

Kunam S. Reddy, Don Stablein, Sarah Taranto et al. · American Journal of Kidney Diseases · 2003 · 243 citations

Type 1, Islet Transplantation, Urology +10

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Merlin L. Robb, Supachai Rerks‐Ngarm, Sorachai Nitayaphan et al. · The Lancet Infectious Diseases · 2012 · 214 citations · Full text

Vaccination, Sexual Health, Preventive Medicine +10

Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1_Mngp120, HIV‐1_SF2Recombinant gp120, or Both Vaccines in Seronegative Adults

Mary Lou Clements‐Mann, Kent J. Weinhold, Thomas J. Matthews et al. · The Journal of Infectious Diseases · 1998 · 190 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +19